Several studies have showed that Prdx1 promotes tumor occurrence mainly by adjusting the levels of ROS, TGF-β1, mTOR/p70S6K, and ROS/ERK/cyclin D1 [47–49]. This evidence concerns the gene RPS6KB1 and neoplasm.